Tigermed-Jyton, a wholly-owned subsidiary of Tigermed Group (Stock code: 300347.SZ/3347.HK), was established in 2000, and is a leading CRO service provider in China for regulatory affairs and clinical research of medical devices (including in vitro diagnostic products), with service covering the whole life cycle of all fields of medical devices. In the past 20 years, we have established long-term cooperative relations with more than 1,700 medical device R&D and manufacture enterprises from more than 30 countries. With our professional service capability, we can reduce registration risk, shorten project timeline, save R&D funds and accelerate the process of product marketization.
Tigermed-Jyton is headquartered in Beijing. Supported by Tigermed Group, we are able to cover 138 cities in China mainland, Hong Kong and Taiwan. Globally, we have set up offices in 15 countries and regions including Korea, Japan, Malaysia, the United States and Europe, etc.
Patient first
Continue to innovate
ISO9001National High-Tech Enterprise National High-Tech Enterprise
CNAS/CMA qualification testing lab
